The viral phoenix: enhanced infectivity and immunity evasion of SARS-CoV-2 variants

Hosoon Choi; Piyali Chatterjee; Munok Hwang; Eric Lichtfouse; Virender K Sharma; Chetan Jinadatha

doi:10.1007/s10311-021-01318-4

The viral phoenix: enhanced infectivity and immunity evasion of SARS-CoV-2 variants

Environ Chem Lett. 2022;20(3):1539-1544. doi: 10.1007/s10311-021-01318-4. Epub 2021 Sep 9.

Authors

Hosoon Choi¹, Piyali Chatterjee¹, Munok Hwang¹, Eric Lichtfouse², Virender K Sharma³, Chetan Jinadatha^{1

4}

Affiliations

¹ Central Texas Veterans Health Care System, 1901 Veterans Memorial Drive, Temple, TX USA.
² Aix-Marseille University, CNRS, IRD, INRAE, CEREGE, Aix en Provence, 13100 France.
³ Program of the Environment and Sustainability, Department of Environmental and Occupational Health, School of Public Health, Texas A&M University, College Station, TX 77843 USA.
⁴ College of Medicine, Texas A&M University, College Station, TX 77842-3012 USA.

Abstract

SARS-CoV-2 pandemic continues with emergence of new variants of concerns. These variants are fueling the third and fourth waves of pandemic across many nations. Here we describe the new emerging variants of SARS-CoV-2 and why they have enhanced infectivity and possess the ability to evade immunity.

Publication types

Editorial